Cho Soo-Kyung, Jeon Yena, Kim Jung-Hyo, Jang Eun Jin, Jung Sun-Young, Sung Yoon-Kyoung
Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seongdong-gu, Korea (the Republic of).
Hanyang University Institute for Rheumatology Research, Seongdong-gu, Korea (the Republic of).
Lupus Sci Med. 2025 Feb 26;12(1):e001361. doi: 10.1136/lupus-2024-001361.
To evaluate the mortality patterns of SLE and the associated risk factors in Koreans.
Using the National Health Insurance database spanning 2008 to 2018, incident cases of SLE in patients aged 10-79 years were included. We analysed the all-cause mortality and cause-specific mortality, stratifying by sex and age. The mortality rate (MR) was calculated as the number of deaths per 100 000 person-years (PYs). The causes of death were identified by the International Classification of Diseases, 10th Revision codes during hospitalisation or emergency visit prior to death. A generalised estimating equation model was employed for risk factor analysis.
In total, 11 375 incident SLE cases among patients with an average age of 42.3±16.7 years were recruited (86.1% female). During 57 658 PYs, 728 deaths occurred (MR 1262.62/100 000 PYs). The MR among men (2718.86/100 000 PYs) exceeded that among women (1060.57/100 000 PYs). The leading causes of death were SLE-related conditions (381.56/100 000 PYs), cardiovascular disease (CVD) (202.92/100 000 PYs), cancer (175.17/100 000 PYs) and infection (143.95/100 000 PYs). Of the SLE-related mortality, the key risk factors were pulmonary complications, such as pulmonary alveolar haemorrhage (OR 9.93), pulmonary arterial hypertension (OR 3.77) and interstitial lung disease (OR 3.27).
Among Korean patients with SLE, SLE-related conditions were the leading causes of mortality. However, CVD and cancer were also identified as the main causes of mortality. Furthermore, pulmonary manifestations were significantly associated with SLE-related mortality.
评估韩国系统性红斑狼疮(SLE)患者的死亡模式及相关危险因素。
利用2008年至2018年的国民健康保险数据库,纳入10至79岁的SLE新发病例。我们分析了全因死亡率和特定病因死亡率,并按性别和年龄进行分层。死亡率(MR)计算为每10万人年(PYs)的死亡人数。通过死亡前住院或急诊就诊期间的国际疾病分类第10版编码确定死因。采用广义估计方程模型进行危险因素分析。
共纳入11375例平均年龄为42.3±16.7岁的SLE新发病例(86.1%为女性)。在57658人年期间,发生728例死亡(MR为1262.62/100000人年)。男性的MR(2718.86/100000人年)超过女性(1060.57/100000人年)。主要死因是SLE相关疾病(381.56/100000人年)、心血管疾病(CVD)(202.92/100000人年)、癌症(175.17/100000人年)和感染(143.95/100000人年)。在SLE相关死亡中,关键危险因素是肺部并发症,如肺泡出血(OR 9.93)、肺动脉高压(OR 3.77)和间质性肺疾病(OR 3.27)。
在韩国SLE患者中,SLE相关疾病是主要死因。然而,CVD和癌症也被确定为主要死因。此外,肺部表现与SLE相关死亡显著相关。